TIMOPTIC Safety Questions, TIMOPTIC Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about TIMOPTIC. Our extensive database of TIMOPTIC adverse events and TIMOPTIC warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about TIMOPTIC

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




TIMOPTIC Safety Reports

Total TIMOPTIC reports: 44.
TIMOPTIC FDA safety alerts: No.
Reported deaths: 3    Reported hospitalizations: 23.
Take TIMOPTIC Side Effects Survey or Share Your TIMOPTIC Story. TIMOPTIC Usage.

Consumer or non-health professional from UNITED STATES reported TIMOPTIC problem on Jan 04, 2007. Female patient, 76 years of age, was diagnosed with glaucoma and was treated with TIMOPTIC. After drug was administered, patient experienced the following problems/side effects: brain neoplasm, dysgeusia, feeling abnormal, gallbladder disorder, transient ischaemic attack. TIMOPTIC dosage: unknown. During the same period patient was treated with SYNTHROID, MYSOLINE, LOTREL. Patient recovered.

TIMOPTIC problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 20, 2007. Male patient, 78 years of age, was diagnosed with glaucoma and was treated with TIMOPTIC. After drug was administered, patient experienced the following problems/side effects: accidental overdose, dry eye, eye pain, intraocular pressure increased, myocardial infarction. TIMOPTIC dosage: unknown. During the same period patient was treated with ASPIRIN, ATENOLOL, OMEPRAZOLE, RAMIPRIL, ATORVASTATIN CALCIUM. Patient recovered.

Physician from JAPAN reported TIMOPTIC problem on Feb 21, 2007. Female patient, 70 years of age, was diagnosed with glaucoma and was treated with TIMOPTIC. After drug was administered, patient experienced the following problems/side effects: conjunctival disorder, hypopyon, ulcerative keratitis. TIMOPTIC dosage: unknown. During the same period patient was treated with XALATAN. Patient was hospitalized. Patient recovered.

TIMOPTIC problem was reported by a Physician from UNITED KINGDOM on Mar 01, 2007. Male patient, 78 years of age, weighting 165.3 lb, was diagnosed with glaucoma, ischaemic heart disease prophylaxis, myocardial ischaemia, dyspepsia, hypertension, lipids increased and was treated with TIMOPTIC. After drug was administered, patient experienced the following problems/side effects: accidental overdose, dry eye, eye pain, intraocular pressure increased, myocardial infarction. TIMOPTIC dosage: unknown. During the same period patient was treated with ASPIRIN, ATENOLOL, OMEPRAZOLE, RAMIPRIL, ATORVASTATIN CALCIUM. Patient recovered.

Health Professional from UNITED STATES reported TIMOPTIC problem on Mar 06, 2007. Male patient, 80 years of age, was diagnosed with intraocular pressure increased and was treated with TIMOPTIC. After drug was administered, patient experienced the following problems/side effects: eye irritation. TIMOPTIC dosage: unknown. During the same period patient was treated with SYNTHROID, FOSAMAX, VASOTEC, LIPITOR. Patient recovered.

TIMOPTIC problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 27, 2007. Female patient was treated with TIMOPTIC. After drug was administered, patient experienced the following problems/side effects: amnesia, ocular hypertension, senile dementia. TIMOPTIC dosage: unknown. During the same period patient was treated with ALPHAGAN. Patient recovered.

Physician from UNITED KINGDOM reported TIMOPTIC problem on Mar 13, 2007. Female patient, 67 years of age, was diagnosed with glaucoma and was treated with TIMOPTIC. After drug was administered, patient experienced the following problems/side effects: deafness, dizziness, tinnitus. TIMOPTIC dosage: unknown. During the same period patient was treated with LATANOPROST. Patient recovered.

TIMOPTIC problem was reported by a Physician from JAPAN on Mar 14, 2007. Female patient, 75 years of age, weighting 99.21 lb, was diagnosed with glaucoma and was treated with TIMOPTIC. After drug was administered, patient experienced the following problems/side effects: hypopyon, ulcerative keratitis. TIMOPTIC dosage: unknown. During the same period patient was treated with XALATAN, TRUSOPT, SANPILO, RESCULA, BETAXOLOL HYDROCHLORIDE. Patient was hospitalized and became disabled. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TIMOPTIC problem on Mar 13, 2007. Female patient was treated with TIMOPTIC. After drug was administered, patient experienced the following problems/side effects: halo vision. TIMOPTIC dosage: unknown. During the same period patient was treated with TRAVATAN. Patient recovered.

TIMOPTIC problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 13, 2007. Female patient was treated with TIMOPTIC. After drug was administered, patient experienced the following problems/side effects: halo vision. TIMOPTIC dosage: unknown. During the same period patient was treated with TRAVATAN. Patient recovered.

Health Professional from UNITED KINGDOM reported TIMOPTIC problem on Mar 19, 2007. Male patient, 76 years of age, was diagnosed with open angle glaucoma and was treated with TIMOPTIC. After drug was administered, patient experienced the following problems/side effects: blepharoplasty, conjunctival oedema, dermatitis, ectropion, erythema, periorbital oedema, skin exfoliation. TIMOPTIC dosage: unknown. During the same period patient was treated with BRIMONIDINE TARTRATE, TRUSOPT, LATANOPROST. Patient was hospitalized. Patient recovered.

TIMOPTIC problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 18, 2007. Male patient, 76 years of age, was diagnosed with open angle glaucoma and was treated with TIMOPTIC. After drug was administered, patient experienced the following problems/side effects: ectropion. TIMOPTIC dosage: unknown. During the same period patient was treated with ALPHAGAN, TRUSOPT, XALATAN. Patient was hospitalized. Patient recovered.

Physician from FRANCE reported TIMOPTIC problem on Apr 19, 2007. Female patient, 63 years of age, weighting 112.4 lb, was diagnosed with glaucoma, diabetes mellitus insulin-dependent, hypertension and was treated with TIMOPTIC. After drug was administered, patient experienced the following problems/side effects: sinoatrial block. TIMOPTIC dosage: unknown. During the same period patient was treated with INSULIN, DILTIAZEM HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

TIMOPTIC problem was reported by a Physician from JAPAN on Apr 25, 2007. Female patient, 77 years of age, weighting 99.21 lb, was diagnosed with glaucoma and was treated with TIMOPTIC. After drug was administered, patient experienced the following problems/side effects: hypopyon, ulcerative keratitis. TIMOPTIC dosage: unknown. During the same period patient was treated with XALATAN, DIAMOX. Patient was hospitalized and became disabled. Patient recovered.

Physician from ITALY reported TIMOPTIC problem on May 03, 2007. Female patient, 59 years of age, was diagnosed with atrial fibrillation and was treated with TIMOPTIC. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, blood cholesterol increased, cardiac arrest, dilatation atrial, hypotension, mitral valve incompetence, tricuspid valve incompetence, ventricular hypertrophy. TIMOPTIC dosage: unknown. During the same period patient was treated with PROPAFENONE HYDROCHLORIDE, HEPARIN LOW MOLECULAR WEIGHT. Patient was hospitalized. Patient recovered.

TIMOPTIC problem was reported by a Consumer or non-health professional from UNITED KINGDOM on May 08, 2007. Male patient, 76 years of age, was diagnosed with open angle glaucoma and was treated with TIMOPTIC. After drug was administered, patient experienced the following problems/side effects: blepharoplasty, conjunctival oedema, dermatitis, ectropion, erythema, periorbital oedema, skin exfoliation. TIMOPTIC dosage: unknown. During the same period patient was treated with ALPHAGAN, TRUSOPT, XALATAN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from CANADA reported TIMOPTIC problem on May 09, 2007. Female patient was diagnosed with open angle glaucoma and was treated with TIMOPTIC. After drug was administered, patient experienced the following problems/side effects: cardiogenic shock, myocardial infarction. TIMOPTIC dosage: unknown. During the same period patient was treated with LATANOPROST. Patient died.

TIMOPTIC problem was reported by a Consumer or non-health professional from UNITED KINGDOM on June 01, 2007. Male patient, 76 years of age, was diagnosed with open angle glaucoma and was treated with TIMOPTIC. After drug was administered, patient experienced the following problems/side effects: blepharoplasty, conjunctival oedema, dermatitis, ectropion, erythema, periorbital oedema, skin exfoliation. TIMOPTIC dosage: unknown. During the same period patient was treated with ALPHAGAN, TRUSOPT, XALATAN. Patient was hospitalized. Patient recovered.

Health Professional from UNITED KINGDOM reported TIMOPTIC problem on Mar 19, 2007. Male patient, 76 years of age, was diagnosed with open angle glaucoma and was treated with TIMOPTIC. After drug was administered, patient experienced the following problems/side effects: blepharoplasty, conjunctival oedema, dermatitis, ectropion, erythema, periorbital oedema, skin exfoliation. TIMOPTIC dosage: unknown. During the same period patient was treated with BRIMONIDINE TARTRATE, DORZOLAMIDE HYDROCHLORIDE, LATANOPROST. Patient was hospitalized. Patient recovered.

TIMOPTIC problem was reported by a Consumer or non-health professional from UNITED KINGDOM on June 01, 2007. Male patient, 76 years of age, was diagnosed with open angle glaucoma and was treated with TIMOPTIC. After drug was administered, patient experienced the following problems/side effects: blepharoplasty, conjunctival oedema, dermatitis, ectropion, erythema, periorbital oedema, skin exfoliation. TIMOPTIC dosage: unknown. During the same period patient was treated with ALPHAGAN, TRUSOPT, XALATAN. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported TIMOPTIC problem on Feb 10, 2006. Female patient, 51 years of age, weighting 114.6 lb, was diagnosed with glaucoma and was treated with TIMOPTIC. After drug was administered, patient experienced the following problems/side effects: blood potassium increased, metabolic acidosis, renal failure, renal tubular acidosis, soft tissue disorder. TIMOPTIC dosage: unknown. During the same period patient was treated with XALATAN. Patient was hospitalized. Patient recovered.

TIMOPTIC problem was reported by a Physician from JAPAN on Feb 10, 2006. Female patient, 51 years of age, weighting 114.6 lb, was diagnosed with glaucoma and was treated with TIMOPTIC. After drug was administered, patient experienced the following problems/side effects: blood potassium increased, kidney fibrosis, renal tubular acidosis. TIMOPTIC dosage: unknown. During the same period patient was treated with XALATAN. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported TIMOPTIC problem on May 18, 2006. Female patient, 56 years of age, weighting 108.0 lb, was diagnosed with intraocular pressure increased, conjunctival hyperaemia, conjunctivitis and was treated with TIMOPTIC. After drug was administered, patient experienced the following problems/side effects: breast cancer metastatic, cataract nuclear, cataract subcapsular, keratopathy, metastases to central nervous system, metastases to lymph nodes, vocal cord paralysis. TIMOPTIC dosage: unknown. During the same period patient was treated with LEVOFLOXACIN, FLUMETHOLON. Patient was hospitalized. Patient died on 10/12/2005.

TIMOPTIC problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 16, 2006. Female patient was treated with TIMOPTIC. After drug was administered, patient experienced the following problems/side effects: amnesia, hyponatraemia, impaired driving ability. TIMOPTIC dosage: unknown. During the same period patient was treated with ALPHAGAN P. Patient recovered.

Physician from JAPAN reported TIMOPTIC problem on Feb 10, 2006. Female patient, 51 years of age, weighting 114.6 lb, was diagnosed with glaucoma and was treated with TIMOPTIC. After drug was administered, patient experienced the following problems/side effects: blood potassium increased, kidney fibrosis, renal tubular acidosis. TIMOPTIC dosage: unknown. During the same period patient was treated with XALATAN. Patient was hospitalized. Patient recovered.

TIMOPTIC problem was reported by a Health Professional from DENMARK on Sept 15, 2006. Female patient, 47 years of age, weighting 127.9 lb, was diagnosed with glaucoma and was treated with TIMOPTIC. After drug was administered, patient experienced the following problems/side effects: alopecia areata, hyperthyroidism. TIMOPTIC dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TIMOPTIC problem on Sept 06, 2006. Female patient, 89 years of age, was diagnosed with glaucoma and was treated with TIMOPTIC. After drug was administered, patient experienced the following problems/side effects: asthenopia, eye infection, eye irritation, paralysis. TIMOPTIC dosage: unknown. Patient recovered.

TIMOPTIC problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 06, 2006. Female patient, 89 years of age, was diagnosed with glaucoma and was treated with TIMOPTIC. After drug was administered, patient experienced the following problems/side effects: asthenopia, eye infection, eye irritation, paralysis. TIMOPTIC dosage: unknown. Patient recovered.

Pharmacist from UNITED KINGDOM reported TIMOPTIC problem on Oct 26, 2006. Male patient, 82 years of age, was treated with TIMOPTIC. After drug was administered, patient experienced the following problems/side effects: bradycardia, respiratory disorder. TIMOPTIC dosage: unknown. Patient was hospitalized. Patient recovered.

TIMOPTIC problem was reported by a Health Professional from UNITED KINGDOM on Nov 06, 2006. Female patient, 82 years of age, weighting 282.2 lb, was diagnosed with glaucoma, diabetes mellitus, hypertension and was treated with TIMOPTIC. After drug was administered, patient experienced the following problems/side effects: dyspnoea, hyperventilation. TIMOPTIC dosage: unknown. During the same period patient was treated with AMARYL, AMLODIPINE BESYLATE, PERINDOPRIL, XALATAN. Patient recovered.

Physician from GERMANY reported TIMOPTIC problem on Oct 24, 2006. Male patient, 74 years of age, was treated with TIMOPTIC. After drug was administered, patient experienced the following problems/side effects: sudden hearing loss. TIMOPTIC dosage: unknown. During the same period patient was treated with CORTISONE ACETATE, TERBINAFINE. Patient was hospitalized. Patient recovered.

TIMOPTIC problem was reported by a Health Professional from UNITED KINGDOM on Nov 10, 2006. Male patient, 72 years of age, was diagnosed with keratitis herpetic and was treated with TIMOPTIC. After drug was administered, patient experienced the following problems/side effects: corneal deposits. TIMOPTIC dosage: unknown. During the same period patient was treated with PREDNISOLONE, ACYCLOVIR, ACETAZOLAMIDE. Patient recovered.

Health Professional from UNITED KINGDOM reported TIMOPTIC problem on Nov 22, 2006. Female patient, 70 years of age, was diagnosed with glaucoma, arthralgia, heart rate, migraine and was treated with TIMOPTIC. After drug was administered, patient experienced the following problems/side effects: chest pain, dyspnoea exertional. TIMOPTIC dosage: unknown. During the same period patient was treated with LATANOPROST, ACETAMINOPHEN AND PROPOXYPHENE HYDROCHLORIDE, ESTRADIOL, SUMATRIPTAN, TRAMADOL. Patient recovered.

TIMOPTIC problem was reported by a Health Professional from FRANCE on Dec 05, 2006. Female patient, 57 years of age, was diagnosed with open angle glaucoma, essential hypertension and was treated with TIMOPTIC. After drug was administered, patient experienced the following problems/side effects: optic neuritis. TIMOPTIC dosage: unknown. During the same period patient was treated with KERLONE. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported TIMOPTIC problem on Dec 08, 2006. Female patient, 30 years of age, was diagnosed with intraocular pressure test and was treated with TIMOPTIC. After drug was administered, patient experienced the following problems/side effects: diabetic hyperglycaemic coma. TIMOPTIC dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.

TIMOPTIC problem was reported by a Health Professional from SPAIN on June 27, 2007. Male patient, 36 years of age, weighting 178.6 lb, was diagnosed with glaucoma, proctocolitis, peptic ulcer haemorrhage, prophylaxis, spondyloarthropathy, essential hypertension, bone disorder and was treated with TIMOPTIC. After drug was administered, patient experienced the following problems/side effects: gynaecomastia. TIMOPTIC dosage: unknown. During the same period patient was treated with PREDNISONE, RABEPRAZOLE, FENTANYL, CANDESARTAN CILEXETIL, TRAVOPROST, MESALAMINE, RISEDRONATE. Patient recovered.

Health Professional from SPAIN reported TIMOPTIC problem on June 27, 2007. Male patient, 36 years of age, weighting 178.6 lb, was diagnosed with glaucoma, proctocolitis, peptic ulcer haemorrhage, prophylaxis, spondyloarthropathy, essential hypertension, bone disorder and was treated with TIMOPTIC. After drug was administered, patient experienced the following problems/side effects: gynaecomastia. TIMOPTIC dosage: unknown. During the same period patient was treated with DACORTIN, PARIET, DURAGESIC, ATACAND, TRAVATAN, CLAVERSAL, ACTONEL. Patient recovered.

TIMOPTIC problem was reported by a Physician from SPAIN on July 02, 2007. Female patient, 68 years of age, was diagnosed with ocular hypertension and was treated with TIMOPTIC. After drug was administered, patient experienced the following problems/side effects: choroidal detachment, hypotony of eye, maculopathy. TIMOPTIC dosage: unknown. Patient recovered.

Physician from SPAIN reported TIMOPTIC problem on July 02, 2007. Female patient, 40 years of age, was diagnosed with ocular hypertension and was treated with TIMOPTIC. After drug was administered, patient experienced the following problems/side effects: choroidal detachment, hypotony of eye. TIMOPTIC dosage: unknown. Patient recovered.

TIMOPTIC problem was reported by a Health Professional from UNITED KINGDOM on Aug 24, 2007. Female patient, 77 years of age, was diagnosed with glaucoma and was treated with TIMOPTIC. After drug was administered, patient experienced the following problems/side effects: blepharitis, conjunctival hyperaemia, disorientation, visual field defect. TIMOPTIC dosage: unknown. During the same period patient was treated with BIMATOPROST, ALPHAGAN. Patient was hospitalized. Patient recovered.

Health Professional from UNITED KINGDOM reported TIMOPTIC problem on Sept 03, 2007. Female patient, 77 years of age, was diagnosed with glaucoma and was treated with TIMOPTIC. After drug was administered, patient experienced the following problems/side effects: blepharitis, conjunctival hyperaemia, disorientation, visual field defect. TIMOPTIC dosage: unknown. During the same period patient was treated with BIMATOPROST, ALPHAGAN. Patient was hospitalized. Patient recovered.

TIMOPTIC problem was reported by a Physician from UNITED KINGDOM on Sept 17, 2007. Female patient, 85 years of age, was diagnosed with glaucoma, cardiac failure congestive, osteoporosis, hypercholesterolaemia and was treated with TIMOPTIC. After drug was administered, patient experienced the following problems/side effects: presyncope, therapeutic response unexpected, wheezing. TIMOPTIC dosage: unknown. During the same period patient was treated with BETAXOLOL HYDROCHLORIDE, FUROSEMIDE, RISEDRONATE, CALCIUM CARBONATE, CANDESARTAN, CIPROFIBRATE. Patient died on 01/19/2006.

Health Professional from UNITED KINGDOM reported TIMOPTIC problem on Sept 14, 2007. Female patient, 77 years of age, was diagnosed with glaucoma and was treated with TIMOPTIC. After drug was administered, patient experienced the following problems/side effects: blepharitis, conjunctival hyperaemia, disorientation, visual field defect. TIMOPTIC dosage: unknown. During the same period patient was treated with BIMATOPROST, BRIMONIDINE TARTRATE. Patient was hospitalized. Patient recovered.

TIMOPTIC problem was reported by a Consumer or non-health professional from NEW ZEALAND on Sept 25, 2007. Female patient, 84 years of age, weighting 132.3 lb, was diagnosed with glaucoma and was treated with TIMOPTIC. After drug was administered, patient experienced the following problems/side effects: ageusia, anosmia, cataract. TIMOPTIC dosage: unknown. During the same period patient was treated with ETIDRONATE DI, ACETAMINOPHEN, ATORVASTATIN CALCIUM, METOPROLOL, PANTOPRAZOLE, FUROSEMIDE, CANDESARTAN, DICLOFENAC. Patient was hospitalized. Patient recovered.

Ask Our Patient Community about TIMOPTIC

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant

Pemetrexed
PemolineThis drug has as active FDA Safety Alert
Pentobarbital and carbromal
Perflutren lipid microspheres
PerindoprilThis drug has as active FDA Safety Alert
PhenerganThis drug has as active FDA Safety Alert (promethazine)
Pimecrolimus

PioglitazoneThis drug has as active FDA Safety Alert
Placidyl (ethchlorvynol)
Plan B (levonorgestrel)
Pletal (cilostazol)
Poractant alfa
Posaconazole
Pramlintide Acetate
Precedex (dexmedetomidine)
PregabalinThis drug has as active FDA Safety Alert
Prezista (darunavir)
Prialt (ziconotide)
Priftin (rifapentine)
PrinivilThis drug has as active FDA Safety Alert (lisinopril)
ProcritThis drug has as active FDA Safety Alert (epoetin alfa)
ProHanceThis drug has as active FDA Safety Alert (gadoteridol)
PromethazineThis drug has as active FDA Safety Alert
PropofolThis drug has as active FDA Safety Alert
Prosom (estazolam)
Protonix (pantoprazole)
Protopic (tacrolimus)
Provigil (modafinil)
ProzacThis drug has as active FDA Safety Alert (fluoxetine)
Prussian blue


back to top

Q
Quazepam
Quetiapine

QuinaprilThis drug has as active FDA Safety Alert
Quinupristin

R
Rabeprazole
Radiogardase
(prussian blue)
Ramelteon
RamiprilThis drug has as active FDA Safety Alert
Ranexa (ranolazine)
Ranibizumab
Ranolazine
Rapamune (sirolimus)
Raptiva (efalizumab)
Rasagiline
RazadyneThis drug has as active FDA Safety Alert (galantamine)
Rebetol (ribavirin)
ReclastThis drug has as active FDA Safety Alert (zoledronic acid)
Refludan (lepirudin recombinant)
Relenza (zanamivir)
RelpaxThis drug has as active FDA Safety Alert (eletriptan)
RemeronThis drug has as active FDA Safety Alert (mirtazapine)
Renagel (sevelamer)
Rescula (unoprostone isopropyl)
Restoril (temazepam)
Revatio (sildenafil)
Revlimid (lenalidomide)
Reyataz (atazanavir sulfate)
Ribasphere (ribavarin ribasphere)
Ribavarin ribasphere
Rifapentine
Rifaximin
RisedronateThis drug has as active FDA Safety Alert
Risperdal (risperidone)
Risperidone
Ritalin (methylphenidate)
Ritonavir
RituxanThis drug has as active FDA Safety Alert
RituximabThis drug has as active FDA Safety Alert
Rivastigmine tartrate
RizatriptanThis drug has as active FDA Safety Alert
RocephinThis drug has as active FDA Safety Alert (ceftriaxone)
Rofecoxib
RosuvastatinThis drug has as active FDA Safety Alert
Rozerem (ramelteon)

back to top

S
Sacrosidase
Salmeterol xinafoate

Sanctura (trospium)
Seconal (secobarbital)
Secobarbital
Selzentry
Sensipar (cinacalcet)
Serevent Diskus (salmeterol xinafoate)
Seroquel (quetiapine)
Sertaconazole
SertralineThis drug has as active FDA Safety Alert
SerzoneThis drug has as active FDA Safety Alert (nefazodone)
Sevelamer
Sildenafil citrate
Sirolimus
Simvastatin
Sitagliptin phosphate
SkelidThis drug has as active FDA Safety Alert (tiludronate)
Sodium ferric gluconate complex
Sodium phosphatesThis drug has as active FDA Safety Alert
Solage (mequinol; tretinoin)
Soliris (eculizumab)
Solifenacin succinate
Somavert (pegvisomant)
Sonata (zaleplon)
Sorafenib
SotretThis drug has as active FDA Safety Alert (isotretinoin)
Spectracef (cefditoren pivoxil)
Spiriva (tiotropium bromide)
Sprycel (dasatinib)
Starlix (nateglinide)
Stimate Nasal SprayThis drug has as active FDA Safety Alert(desmopressin)
StratteraThis drug has as active FDA Safety Alert (atomoxetine)
Sucraid (sacrosidase)